Metabolic & Endocrine Therapies

RyGen Biopharma develops biologic therapies focused on treating metabolic and endocrine disorders such as diabetes, obesity, and related hormonal conditions. These therapies are designed to regulate metabolic functions, improve glucose control, and support overall metabolic health.

Using advanced recombinant DNA technology, our development programs target innovative biologics that help manage chronic metabolic diseases and enhance patient outcomes. RyGen aims to deliver safe, effective, and high-quality treatments aligned with global regulatory standards and modern healthcare needs.